« Glucagon-like Peptide-1 Receptor Agonists and Thyroid Cancer: Myth or Reality? », Can Diabetes Endocrinol Today, vol. 3, nᵒ 1, p. 17–22, mai 2025, doi: 10.58931/cdet.2025.3137.